7 Companies Racing to Make Sickle Cell Cures Accessible

Since the world's first gene-edited therapy for sickle cell disease won approval, scientists are tackling an urgent new challenge: making these cures simpler, safer, and available to everyone who needs them.

Seven innovative companies are leading the charge to transform a $2.

2 million treatment into something far more practical.